Bristol Myers Squibb · 6 hours ago
Executive Director, Clinical Supply Portfolio Lead, HOCT
Madison - Giralda - NJ - US
Full-time
Onsite
Director/Executive
$274K/yr - $332K/yr
15+ years expBristol Myers Squibb is a company dedicated to transforming patients' lives through science. The Executive Director, Clinical Supply Portfolio Lead will provide strategic direction and operational leadership for clinical supply across Hematology, Oncology, and Cell Therapy portfolios, managing cross-functional teams and ensuring compliance with regulatory requirements.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Ensure consistent strategy development and implementation of integrated clinical supply strategies for the HOCT portfolio, ensuring alignment with organizational goals, regulatory requirements, and patient needs
Provide strategic direction and leadership to the HOCT Therapeutic Area organization
Oversee end-to-end clinical supply chain, including forecasting, planning, inventory management, packaging and labeling campaigns, distribution, site supply, and use date extensions
Ensure compliance with GxP, safety standards, and regulatory requirements across all clinical supply operations
Drive innovation and operational excellence by identifying and implementing process improvements, cost-saving initiatives, and strategic global programs or systems
Shape and optimize matrix team governance and execution, fostering a culture of continuous improvement and accountability
Instill a cost-conscious mindset across the organization, managing comparator/co-med budgets and minimizing waste
Lead resolution of senior-level escalations and issues with portfolio-wide implications
Communicate and align the therapeutic area strategy across cross-functional teams to ensure visibility and execution
Apply leadership development principles, ensuring staff development, succession planning, and a high-performance culture
Solve complex, cross-functional problems, evaluating fundamental issues and intangible variables to drive strategic decisions
Lead clinical supply planning activities for both BMS and non-BMS sponsored research, ensuring timely delivery of finished clinical supplies
Ensure the HOCT team are fully leveraging the capabilities of AI to drive meaningful improvement in ways of working, simplifying processes and releasing resources to focus on more critical areas
Interface and collaborate across CSC TAs for aligned business practices and customer service
Establish key performance indicators that facilitate the identification of improvement opportunities and ensure successful realization of goals and objectives and delivery for the portfolio
Partner with the GDO, finance and CSO organizations to operationalize the CD&OP process, to manage priorities, conflict resolutions across the BMS development processes
Qualification
Required
Bachelor's degree in Pharmacy, Life-Sciences, Supply Chain, Engineering, or related technical field; advanced degree (MBA, PharmD, etc.) preferred
15+ years of experience in pharmaceutical industry, with significant expertise in drug development, clinical supply chain management, and/or clinical manufacturing; 10+ years in managerial roles, including project management, team leadership, and cross-functional stakeholder management. An equivalent combination of education and experience may be considered
Advanced knowledge of clinical trials, supply chain, and logistics best practices, especially in oncology
Strong problem-solving, written/verbal communication, and leadership skills
Experience with strategic sourcing, vendor management, and budget oversight
Demonstrated ability to drive innovation and continuous improvement
Strong leadership, collaboration, and relationship-building skills at the executive level
Proven ability to drive strategic initiatives, manage complex projects, and deliver results in dynamic environments
Deep understanding of regulatory requirements (cGMP, FDA, data privacy) and operational excellence methodologies
Experience developing and implementing global processes for supply chain
Excellent communication, negotiation, and decision-making skills
Commitment to diversity, equity, inclusion, and continuous professional development
Benefits
Health Coverage: Medical, pharmacy, dental, and vision care.
Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
Paid Time Off
US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees)
Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
Based on eligibility*, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.
Company
Bristol Myers Squibb
At Bristol Myers Squibb, we work every day to transform patients’ lives through science.
10001+ employees
H1B Sponsorship
Bristol Myers Squibb has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (247)
2024 (278)
2023 (231)
2022 (180)
2021 (181)
2020 (169)
Funding
Current Stage
Public CompanyTotal Funding
$29.33BKey Investors
Venrock
2025-11-05Post Ipo Debt· $5.75B
2024-02-14Post Ipo Debt· $13B
2023-10-30Post Ipo Debt· $4.5B
Leadership Team
Charles Bancroft
CFO
Cristian Massacesi
Executive Vice President, Chief Medical Officer and Head of Development
Recent News
Labiotech UG
2026-02-07
Company data provided by crunchbase